This site is intended for health professionals only

Home / News / Blood pressure drugs recalled over cancerous substance contamination fears

Blood pressure drugs recalled over cancerous substance contamination fears

blood pressure drugs recalled

By Isabel Shaw
Reporter

10 Aug 2021

The UK’s medicines watchdog has recalled certain batches of irbesartan-containing products, made by several manufacturers, over concerns that the drugs have come into contact with a potentially cancerous substance. 

This is the second time irbesartan-containing products have been recalled by the Medicines Healthcare Regulatory Agency (MHRA), after being recalled in June of this year.  

The products are being recalled as a ‘precautionary measure’ to ‘prevent further exposure,’ following contamination with 5-(4’-(azidomethyl)-[1,1’-biphenyl]-2yl)-1H-tetrazole. 

The recalled lines include batches from Sanofi, Doncaster Pharmaceuticals Group Lt, MPT Pharma Limited, PCO Manufacturing Ltd, ​​Gowrie Laxmico Ltd T/A B&S Healthcare and Zentiva Pharma UK Ltd. 

The identified substance has ‘mutagenic potential,’ which means it could permanently damage or change DNA by causing cancer. 

These batches are being recalled as the level of contamination with the mutagenic substance is above the acceptable limit.  

Healthcare professionals have been told to stop supplying the listed batches immediately, to quarantine all remaining stock and return it to the supplier. 

Irbesartan-containing medicinal products are often used to treat high blood pressure. Patients who are taking the affected medications are advised to consult their health team before stopping taking it, the MHRA said. 

The medicines watchdog said there are no anticipated supply issues of irbesartan-containing products in the UK.  

An investigation into other potentially impacted products is ongoing, they added. 


Want news like this straight to your inbox?


Latest News

Diverse pharmacists needed in senior public health roles, says MP
There needs to be more diverse pharmacists in senior roles across national public health bodies, hospital administration and wider government to achieve equality in...
Anti-smoking drug recalled over nitrosamine concerns
The smoking cessation drug, Champix, has been recalled over concerns the product may contain elevated...
Pharmacies on track to deliver record 3 million flu vaccines
Community pharmacies in England could be on track to administer a record 3 million flu...